Merck Presents Updated Results for Investigational Therapy Tepotinib Demonstrating Durable Clinical


ASCO Abstract # Tepotinib (MET kinase inhibitor): 9005 Not intended for UK- , Canada- or US-based media DARMSTADT, Germany, June 3, 2019 /PRNewswire/ -- -- ... Lees verder

Bron: ANP Pers support
Tags:
Geplaatst: 03 jun 2019 - 19:29